Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

BACKGROUND: Paclitaxel and docetaxel are commonly used for metastatic breast cancer in the People’s Republic of China. To improve the safety and efficacy of paclitaxel, an albumin-bound formulation (nab) is now available in the People’s Republic of China (Abraxane(®)). To provide health economic dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dranitsaris, George, Yu, Bo, King, Jennifer, Kaura, Satyin, Zhang, Adams
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435086/
https://www.ncbi.nlm.nih.gov/pubmed/25999749
http://dx.doi.org/10.2147/CEOR.S82194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435086/
https://www.ncbi.nlm.nih.gov/pubmed/25999749
http://dx.doi.org/10.2147/CEOR.S82194

Ejemplares similares